Duncan Barbara Gayle - Insider Non-Derivative Transactions at HALOZYME THERAPEUTICS, INC. (HALO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 25, 2024, Duncan Barbara Gayle's relationship to HALOZYME THERAPEUTICS, INC. (HALO) is Director, and currently has 15,754 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other HALO insiders.
Data Source: SEC.
Duncan Barbara Gayle - Insider Non-Derivative Transactions of HALO Common Stock
Duncan Barbara Gayle - Insider Non-Derivative Transactions at HALO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 26, 2024 | Acquisition -- (Common Stock) | 6501 | 0 | 15754 |
| May 6, 2023 | Acquisition -- (Common Stock) | 8065 | 0 | 9253 |
| Feb 4, 2023 | Acquisition -- (Common Stock) | 1188 | 0 | 1188 |